Inhibrx Biosciences, Inc. - Neraca (Quarterly)

Inhibrx Biosciences, Inc.
US ˙ NasdaqGS ˙ US45720L1070
HINDI NA ACTIVE ANG SIMBONG ITO

Talaan ng Balanse (Quarterly)

Neraca Inhibrx Biosciences, Inc. menunjukkan saldo akun perusahaan pada titik waktu tertentu. Data Neraca meliputi Aset, Aset Lancar, Aset Tetap, Properti, Pabrik dan Peralatan (PPE), Persediaan, Aset Tak Berwujud, Kewajiban, Kewajiban Lancar, Utang, Kewajiban Sewa Modal, Saham Biasa, Laba Ditahan, Saham Perbendaharaan, dan Ekuitas Pemegang Saham.

Semua angka adalah kelipatan 1,000,000.00 kecuali unit per saham.

2023
12-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Cash 278 227 196 153 217 187
Change (%) -18.37 -13.46 -22.28 41.89 -13.83
Assets Current 295 242 207 160 223 194
Change (%) -18.05 -14.30 -22.68 39.27 -13.17
Assets 308 258 223 181 243 212
Change (%) -16.07 -13.88 -18.78 34.23 -12.58
Liabilities 264 39 44 47 148 144
Change (%) -85.23 12.91 7.00 214.09 -3.13
Equity 44 219 178 134 94 69
Change (%) 404.25 -18.64 -25.15 -29.30 -27.41
Liabilities And Stock Equity 308 258 223 181 243 212
Change (%) -16.07 -13.88 -18.78 34.23 -12.58

Source: Capital IQ

Other Listings
US:INBX US$ 28.18
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista